Inclusion of women susceptible to and becoming pregnant in preregistration clinical trials in low- and middle-income countries: A proposal for neglected tropical diseases

Open Access

The Policy Platform is for authors to discuss policies that could improve the lives of those at risk of, or affected by, the NTDs.

Monique Couderc-Pétry,

Affiliation Pétry Medical Consulting, Suresnes, France
⨯
Elisabeth Eléfant,

Affiliation Reference Center on Teratogenic Agents (CRAT), Armand-Trousseau Hospital, Paris, France
⨯
Monique Wasunna,

Affiliation Drugs for Neglected Diseases initiative, Nairobi, Kenya
⨯
Alwyn Mwinga,

Affiliation Zambia AIDS Related Tuberculosis Project (Zambart), Lusaka, Zambia
⨯
Nilima A. Kshirsagar,

Affiliation Clinical Pharmacology, Indian Council of Medical Research, New Delhi, India
⨯
Nathalie Strub-Wourgaft

* E-mail: nstrub@dndi.org

Affiliation Drugs for Neglected Diseases initiative, Geneva, Switzerland
⨯

Reader Comments (0)

Pregnancy
Is the Subject Area "Pregnancy" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Clinical trials
Is the Subject Area "Clinical trials" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Termination of pregnancy
Is the Subject Area "Termination of pregnancy" applicable to this article?

Thanks for your feedback.
Female contraception
Is the Subject Area "Female contraception" applicable to this article?

Thanks for your feedback.
Low and middle income countries
Is the Subject Area "Low and middle income countries" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.